Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study

Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study

Objectives. Assessing the effectiveness and tolerability of medical cannabis (MC) treatment on Gilles de la Tourette syndrome (GTS) patients. Methods. We report on an open-label, prospective study on the effect of MC on adult GTS patients. MC mode of use was decided by the treating neurologist and t...

Full description

Saved in:
Bibliographic Details
Main Authors: Saar Anis, Corinne Zalomek, Amos D. Korczyn, Alina Rosenberg, Nir Giladi, Tanya Gurevich
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.1155/2022/5141773
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items